02/18/2026
📈 Big news on high-dose Vitamin C! A recent randomized trial found that adding 75g of IV vitamin C to standard chemotherapy in stage IV pancreatic cancer doubled overall survival and reduced the risk of death by about 54% compared with chemo alone. 👀✨ These kinds of results are rare in one of the toughest cancers — and they’ve sparked serious interest in IV vitamin C’s potential role in oncology support.
💡 While this isn’t a cure, it does highlight how nutrient-level therapies at pharmacologic doses may impact outcomes when combined with conventional medicine — and why more research is needed.
